All News about Repare Therapeutics Inc
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_98.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2168.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_35.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_2676.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_304.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_378.jpg)
![](https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2012/biotech2_1.jpg)
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs, And More
October 03, 2021
Via Talk Markets
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech2_1.jpg)
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
October 03, 2021
Via Benzinga
Exposures
Product Safety
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_715.jpeg?width=720)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Repare Therapeutics Appoints Thomas Civik to Its Board and as New Chairman
September 07, 2021
Via Business Wire
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_443.jpeg?width=720)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mika-baumeister-wv1qenlelwi-unsplash_1.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/maxim-hopman-fixlqxahcfk-unsplash_4.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/josh-appel-netpasr-bmq-unsplash_3.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/32215763362_89df25525e_o_13.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/julie-ricard-x9ziglrwx-w-unsplash.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/5045190035_44860d5de6_o_1_0.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/joshua-hoehne-gogyvir1tem-unsplash_0.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medhat-dawoud-f-3muxfly2o-unsplash_1_3.jpg?width=720)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/stephen-l-3kweyop8tt8-unsplash_4.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.